Use of combination of anti-PD-1 antibody and VEGFR inhibitor in preparation of drug for treating cancers
US-12435144-B2 · Oct 7, 2025 · US
This page is not indexed by search engines while we improve data quality.
Cao Guoqing patents
Cao Guoqing is listed as an inventor on 43 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Cao Guoqing |
| Total patents | 43 |
| First publication | Apr 21, 2016 |
| Latest publication | Oct 7, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Discharge control method and apparatus, electronic device, and storage medium
US-2025135890-A1 · May 1, 2025 · US
Dead time determination method, charging driving circuit and apparatus, and device and medium
US-2025132582-A1 · Apr 24, 2025 · US
Circuit and method for suppressing power supply starting surge, charging apparatus, and storage medium
US-2024380222-A1 · Nov 14, 2024 · US
Toxin molecule suitable for antibody-drug conjugate
US-2024132515-A1 · Apr 25, 2024 · US
Use of Combination of Anti-PD-1 Antibody and VEGFR Inhibitor in Preparation of Drug for Treating Cancers
US-2024084013-A1 · Mar 14, 2024 · US
Use of combination of anti-PD-1 antibody and VEGFR inhibitor in preparation of drug for treating cancers
US-11866500-B2 · Jan 9, 2024 · US
PD-L1 antibody, antigen-binding fragment thereof and medical application thereof
US-11780923-B2 · Oct 10, 2023 · US
Anti-CD40 antibody, antigen binding fragment thereof and medical use thereof
US-11525005-B2 · Dec 13, 2022 · US
Use of KOR agonist in combination with MOR agonist in preparing drug for treating pain
US-11471503-B2 · Oct 18, 2022 · US
Recent patents
Latest publications not already listed above.
PD-1 antibody, antigen-binding fragment thereof, and medical application thereof
US-11365255-B2 · Jun 21, 2022 · US
Use of Combination of Anti-PD-1 Antibody and VEGFR Inhibitor in Preparation of Drug for Treating Cancers
US-2022119528-A1 · Apr 21, 2022 · US
Use of combination of anti-PD-1 antibody and VEGFR inhibitor in preparation of drug for treating cancers
US-11208484-B2 · Dec 28, 2021 · US
Anti-4-1bb antibody, antigen-binding fragment thereof and medical use thereof
US-2021363266-A1 · Nov 25, 2021 · US
Use of EZH2 inhibitor combined with BTK inhibitor in preparing drug for treating tumor
US-11065239-B2 · Jul 20, 2021 · US
Use of combination of VEGFR inhibitor and PARP inhibitor in preparation of medicament for treating gastric cancer
US-11000518-B2 · May 11, 2021 · US
Use of ezh2 inhibitor combined with btk inhibitor in preparing drug for treating tumor
US-2021030736-A1 · Feb 4, 2021 · US
Anti-CD27 Antibody, Antigen-binding Fragment Thereof, and Medical Use Thereof
US-2021009706-A1 · Jan 14, 2021 · US
Pd-l1 antibody, antigen-binding fragment thereof and medical application thereof
US-2020399375-A1 · Dec 24, 2020 · US
Use of kor agonist in combination with mor agonist in preparing drug for treating pain
US-2020368309-A1 · Nov 26, 2020 · US
PD-L1 antibody, antigen-binding fragment thereof and medical application thereof
US-10815304-B2 · Oct 27, 2020 · US
Anti-cd40 antibody, antigen binding fragment thereof and medical use thereof
US-2020148778-A1 · May 14, 2020 · US
Anti-gitr antibody, antigen-binding fragment thereof, and pharmaceutical use thereof
US-2020131263-A1 · Apr 30, 2020 · US
Medical use of anti-c met antibody-cytotoxic drug conjugate
US-2020054764-A1 · Feb 20, 2020 · US
Pharmaceutical composition containing mor agonist and kor agonist, and uses thereof
US-2020054594-A1 · Feb 20, 2020 · US
Use of Combination of Anti-PD-1 Antibody and VEGFR Inhibitor in Preparation of Drug for Treating Cancers
US-2020040078-A1 · Feb 6, 2020 · US
Uses of egfr/her2 inhibitor combined with pyrimidine-type anti-metabolic drug
US-2019358212-A1 · Nov 28, 2019 · US
Pd-1 antibody, antigen-binding fragment thereof, and medical application thereof
US-2019309069-A1 · Oct 10, 2019 · US
Use of combination of vegfr inhibitor and parp inhibitor in preparation of medicament for treating gastric cancer
US-2019275021-A1 · Sep 12, 2019 · US
Use of tyrosine-kinase inhibitor in preparing pharmaceutical product for cancer treatment
US-2019224189-A1 · Jul 25, 2019 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Jiangsu Hengrui Medicine Co | 37 |
| Shanghai hengrui pharmaceutical co ltd | 21 |
| Suzhou Suncadia Biopharmaceuticals Co Ltd | 12 |
| Changchun Jetty Automotive Tech Co Ltd | 3 |
| Chilwee Power Co Ltd | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 30 |
| A61K2039/505 | 23 |
| C07K2317/24 | 20 |
| C07K2317/565 | 20 |
| A61K39/395 | 19 |